Cancer research
Researchers from the Medical School of Nanchang University have made a significant discovery in understanding the role of circulating tumor DNA (ctDNA) in predicting long-term outcomes in non-small cell lung cancer (NSCLC) patients. By analyzing ten studies involving 1859 cases, the team found that positive ctDNA-based molecular residual disease (MRD)
Cancer research
Research has unveiled a significant breakthrough in the fight against pleural mesothelioma, a devastating form of cancer affecting the lining surrounding the lungs. By analyzing data from The Cancer Genome Atlas (TCGA) and conducting experimental validations, a team of scientists has developed a novel prognostic gene signature that can accurately
Cancer research
Researchers from the University of Toronto have published a new study on the impact of CRISPR gene editing on cancer research. According to the study, CRISPR tools are transforming the field of oncology by enabling the creation of cancer models, studying tumor evolution, and identifying genes involved in cancer growth
Cancer research
Routine cervical screening should be offered to women aged 65 and over, as they are still at heightened risk of cancer from human papillomavirus (HPV), according to research. The World Health Organization reported that there were about 660,000 cases of cervical cancer and 350,000 deaths from it worldwide
Cancer research
Asian-Americans with high smoking prevalence exhibit low participation in lung cancer screening despite its potential to reduce mortality, according to research findings from Thomas Jefferson University. The study aimed to develop and evaluate the culturally sensitive Connect4LungHealth intervention, which combines mobile text messaging with community health worker support to promote
Cancer research
Investigators from Exact Sciences Corporation conducted a real-world study examining adherence to repeat multi-target stool DNA (mt-sDNA) testing among patients from federally qualified health centers (FQHCs) across the US. The research, published in the Journal of Primary Care & Community Health, analyzed data from 19,536 eligible patients who had
Cancer research
Researchers have made significant strides in understanding the complex genetic underpinnings of lung adenocarcinoma, a leading cause of cancer-related deaths worldwide. A recent study published in the International Journal of Radiation Oncology*Biology*Physics underscores the potential of personalized medicine in treating patients with metastatic lung adenocarcinoma. By analyzing the
Cancer research
Researchers at the Department of Cardiothoracic and Vascular Surgery in Inner Mongolia, People's Republic of China, have reported a case where a 59-year-old female patient with lung adenocarcinoma experienced intestinal obstruction due to small intestine metastasis. The patient's condition deteriorated to intestinal perforation, peritonitis, and infectious
Cancer research
According to a recent study published in ESMO Open, a significant proportion of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) early breast cancer (EBC) are eligible for adjuvant ribociclib (NATALEE) and abemaciclib (monarchE) therapy, demonstrating a potential invasive disease survival benefit when added to standard-of-care
Cancer research
The National Institutes of Health (NIH) conducted a comprehensive study on the impact of hormone therapy on breast cancer risk in women under 55. Researchers analyzed data from over 459,000 women across North America, Europe, Asia, and Australia, revealing that hormone therapy can significantly alter breast cancer risk. Specifically,
Cancer research
Cancer scientists at the National University of Singapore have made a groundbreaking discovery in the field of immunotherapy, developing a novel nanovaccine strategy to target and eliminate cancer stem cells, which cause tumour recurrence and incurability after surgery. The researchers, led by Dr. Gege Wu, propose a nanovaccine called NICER,
Cancer research
Researchers from the National Institute of Pharmaceutical Education and Research (NIPER) have made a groundbreaking discovery in the field of colon cancer treatment. The team, led by Padakanti Sandeep Chary, has developed a self-nanoemulsifying drug delivery system (SNEDDS) that can effectively prevent the efflux of the cancer medication irinotecan, increasing
